SOURCE: Healtheuniverse, Inc.

September 08, 2006 16:00 ET

Healtheuniverse Announces Fat Based Stem Cell Technology Moving to Clinical Trials Without Utilizing Human Embryonic Stem Cells

Techniques Provide Promise of Stem Cell Medical Breakthroughs While Avoiding Destruction of Embryos

COVINA, CA -- (MARKET WIRE) -- September 8, 2006 -- Healtheuniverse, Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced today that the Company's fat based stem cell technology is moving to clinical trials without the use of human embryonic stem cells. The Company is preparing to submit an application through an Independent Institutional Review Board to pursue our clinical trial for the utilization of fat based stem cells. Using this approach provides the promise of stem cell medical breakthroughs while avoiding the controversy surrounding destruction of embryos.

Adipose tissue, also known as fat, is an abundant source of stem cells and other regenerative cells that can contribute to the repair and healing of damaged tissue. Clinical trials will be focused on growing different cell types from adult stem cells utilizing a proprietary process. Therapies utilizing this process have varied applications for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. The clinical trials using adult stem cells are important because they provide the promise of significant medical advancement in the stem cell field while avoiding the controversy of using stem cells from embryos.

Dr. Vipul Dev, M.D. PhD., CEO of Healtheuniverse, Inc. and Plastic and Reconstructive Surgeon, stated, "Fat tissue has the potential to be grown for plastic and reconstructive cases performed daily in our clinics in California. The engineered tissue can initially be used to repair facial deformities, breast reconstruction, and various defects caused by disease or trauma. Our patients would benefit greatly from a customized tissue replacement engineered from their own fat tissue. Significant benefits from these techniques include no negative immune responses since the replacement tissue is from the patient's own cells."

About HEALTHeUNIVERSE, Inc.

HEALTHeUNIVERSE, Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at http://healtheuniverse.com/

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    800-719-7424
    Email Contact